THE company behind one of Alnwick’s biggest employers has signed a four-year agreement for scientific research and development.
Covance, which has facilities off Willowburn Avenue in Alnwick, announced the partnership with Inserm Transfert Initiative last week.
Under the terms of the agreement, Covance will conduct discovery and early development studies, using its global capabilities including those at its facilities in Alnwick as well as Porcheville, France, for projects managed by Inserm Transfert, the knowledge transfer company of Inserm, and pre-clinical studies for start-ups within Inserm Transfert Initiative’s portfolio.
Deborah Tanner, executive vice president and group president, R&D Laboratories, Covance Inc, said: “This agreement marks a significant milestone in strengthening our relationships in Europe, and we are proud to partner with Inserm Transfert and Inserm Transfert Initiative.
“By contributing our scientific and operational expertise, we aim to accelerate development of the companies’ innovative research and development projects and, ultimately, help deliver medical and scientific breakthroughs.”